Business Context and Reporting Period
This Form 6-K filing by Powell Max Ltd (PMAX) covers the month of March 2025, with a specific reporting date of March 11, 2025. The filing addresses a regulatory notice regarding the company's continued listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a listing deficiency notice rather than financial performance data.
Material Changes
The primary material change is the receipt of a deficiency notice from Nasdaq on March 5, 2025. The notice states that the closing bid price for the Company's Class A Ordinary Shares has been below $1.00 per share for 30 consecutive business days, resulting in non-compliance with the Minimum Bid Price Rule.
Outlook, Risks, and Contingencies
- Compliance Timeline: The Company has 180 calendar days, until September 1, 2025, to regain compliance. Compliance is achieved if the closing bid price is at least $1.00 per share for 10 consecutive business days.
- Extension Possibility: If compliance is not met by September 1, 2025, the Company may be eligible for an additional 180-day period (maximum 360 days total), provided it meets market value of publicly held shares requirements and other initial listing standards.
- Delisting Risk: Failure to cure the deficiency within the second compliance period will result in a delisting notice. The Company may appeal this determination to the Nasdaq Listing Qualifications Hearings Panel.
- Trading Status: The notice has no immediate effect on trading; shares will continue to trade under the symbol "PMAX" without interruption at this time.
- Management Commentary: Management intends to actively monitor the share price and consider available options to resolve the deficiency, though there is no assurance of success.
Investor Verification Checklist
- Verify the current closing bid price of PMAX shares to assess proximity to the $1.00 threshold.
- Monitor the company's ability to maintain a $1.00 closing price for 10 consecutive business days before September 1, 2025.
- Review future filings for any announcements regarding reverse stock splits or other corporate actions intended to cure the deficiency.
- Check for any subsequent notices from Nasdaq regarding the extension of the compliance period or delisting proceedings.